S-Nitrosylated tissue-type plasminogen activator protects against myocardial ischemia/reperfusion injury in cats: Role of the endothelium

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 3, 1996, Pages 1174-1180

  Delyani, John A ^a,c   Nossuli, Tareck O ^a,c   Scalia, Rosario ^a   Thomas, George ^b   Garvey, David S ^b   Lefer, Allan M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NitroMed Research Laboratories   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; PADGEM PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAT; CONTROLLED STUDY; DRUG MECHANISM; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART PROTECTION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; VASCULAR ENDOTHELIUM;

ANIMALS; CATS; CELL ADHESION; CORONARY VESSELS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HEMODYNAMIC PROCESSES; IMMUNOHISTOCHEMISTRY; MUSCLE RELAXATION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NECROSIS; NEUTROPHILS; NITROSO COMPOUNDS; P-SELECTIN; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0030439040     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. BATH, P. M. W.: The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro. Eur. J. Clin. Pharmacol. 45: 53-58, 1993.
2. BRAUNWALD, E. AND KLONER, R. A.: Myocardial reperfusion: A double edged sword? J. Clin. Invest. 76: 1713-1719, 1985.
3. x-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J. Clin. Invest. 93: 1140-1148, 1994.
4. DAVENPECK, K. L., GAUTHIER, T. W., ALBERTINE, K. AND LEFER, A. M.: Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion. Am. J. Physiol. 267: H622-H630, 1994a.
5. DAVENPECK, K., GAUTHIER, T. W. AND LEFER, A. M.: Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 107: 1050-1058, 1994b.
6. ENTMAN, M. L. AND SMITH, C. W.: Postreperfusion inflammation: A model for reaction to injury in cardiovascular disease. Cardiovasc. Res. 28: 1301-1311, 1994.
7. FUKUDA, H., SAWA, Y., KADOBA, K., TANIGUCHI, K., SHIMAZAKI, Y. AND MATSUDO, H.: Supplement of nitric oxide attenuates neutrophil-mediated reperfusion injury. Circulation 92: suppl. II, II413-II416, 1995.
8. GAUTHIER, T. W., DAVENPECK, K. L. AND LEFER, A. M.: Nitric oxide attenuates leukocyte-endothelial cell interaction via P-selectin in splanchnic ischemia-reperfusion. Am. J. Physiol. 267: G562-G568, 1994.
9. GAUTHIER, T. W., SCALIA, R., MUROHARA, T., GUO, J.-P. AND LEFER, A. M.: Nitric oxide protects against leukocyte-endothelial interactions in the early stages of hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 15: 1652-1659, 1995.
10. GERSH, B. J. AND ANDERSON, J. L.: Thrombolysis and myocardial salvage: Results of clinical trials and the animal paradigm - paradox or predictable? Circulation 88: 296-306, 1993.
11. GROVES, P. H., LEWIS, M. J., CHEADLE, H. A. AND PENNY, W. J.: SIN-1 reduces platelet adhesion and platelet thrombus formation in a porcine model of balloon angioplasty. Circulation 87: 590-597, 1993.
12. JOHNSON, G., III, TSAO, P. S. AND LEFER, A. M.: Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit. Care Med. 19: 244-252, 1991.
13. KUBES, P. AND GRANGER, D. N.: Nitric oxide modulates microvascular permeability. Am. J. Physiol. 262: H611-H615, 1992.
14. KUBES, P., KUROSE, I. AND GRANGER, D. N.: NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am. J. Physiol. 267: H931-H937, 1994.
15. KUBES, P., SUZUKI, M. AND GRANGER, D. N.: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. U.S.A. 88: 4651-4655, 1991.
16. LAFRADO, L. J. AND OLSON, R. G.: Demonstration of depressed polymorphonuclear leukocyte function in nonviremic FELV-infected cats. Cancer Invest. 4: 297-300, 1986.
17. LEFER, A. M. AND LEFER, D. J.: Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu. Rev. Pharmacol. Toxicol. 33: 71-90, 1993.
18. LEFER, A. M. AND MA, X.-L.: Decreased basal nitric oxide release in hypercholesterolemia increased neutrophil adherence to rabbit coronary artery endothelium. Arterioscler. Thromb. 13: 771-776, 1993.
19. LEFER, A. M., MENTLEY, R. AND SUN, J.-Z.: Potentiation of myocardial salvage by tissue type plasminogen activator in combination with a thromboxane synthetase inhibitor in ischemic cat myocardium. Circ. Res. 63: 621-627, 1988.
20. LEFER, D. J., NAKANISHI, K., JOHNSTON, W. E. AND VINTEN-JOHANSEN, J.: Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 88: 2337-2350, 1993.
21. LEVIN, E. G.: Latent tissue plasminogen activator produced by human endothelial cells in culture: Evidence for an enzyme inhibitor complex. Proc. Natl. Acad. Sci. U.S.A. 80: 6804-6808, 1983.
22. LIM, M. J., GALLAGHER, M. A., ZIADEH, M. AND BUDA, A. J.: Effect of coronary reocclusion after initial reperfusion on ventricular function and infarct size. J. Am. Coll. Cardiol. 18: 879-885, 1991.
23. LOSCALZO, J. AND VAUGHAN, D. E.: Tissue plasminogen activator promotes platelet disaggregation in plasma. J. Clin. Invest. 79: 1748-1755, 1987.
24. MA, X.-L., LEFER, D. J., LEFER, A. M. AND ROTHLEIN, R.: Coronary and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 86: 937-946, 1992.
25. MA, X.-L., WEYRICH, A. S., LEFER, D. J. AND LEFER, A. M.: Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ. Res. 72: 403-412, 1993.
26. MARDER, V. J. AND SHERRY, S.: Thrombolytic therapy: Current status. N. Engl. J. Med. 318: 1512-1520, 1988.
27. MOILANEN, E., VUORINEN, P., KANKAANRANTA, H., METSA-KETELA, T. AND VAPAATALO, H.: Inhibition by nitric oxide-donors of human polymorphonuclear leukocyte functions. Br. J. Pharmacol. 109: 852-858, 1993.
28. PABLA, R., BUDA, A. J., FLYNN, D. M., BLESSÉ, S. A., SHIN, A. M., CURTIS, M. J. AND LEFER, D. J.: Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ. Res. 78: 65-72, 1996.
29. RADOMSKI, M. W. AND MONCADA, S.: The biological and pharmacological role of nitric oxide in platelet function. Adv. Exp. Med. Biol. 344: 251-264, 1993.
30. ROMSON, J. L., HOOK, B. G., KUNKEL, S. L., ABRAMS, G. D., SCHORK, M. A. AND LUCCHESI, B. R.: Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67: 1016-1023, 1983.
31. SIEGFRIED, M. R., ERHARDT, J., RIDER, J. T., MA, X.-L. AND LEFER, A. M.: Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J. Pharmacol. Exp. Ther. 260: 668-675, 1992.
32. SMITH, C. W., MARLIN, S. D., ROTHLEIN, R., TOMAN, C. AND ANDERSON, D. C.: Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J. Clin. Invest. 83: 2008-2017, 1989.
33. STAMLER, J. S., SIMON, D. I., JARAKI, O., OSBORNE, J. A., FRANCIS, S., MULLINS, M., SINGEL, D. AND LOSCALZO, J.: S-Nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. Proc. Natl. Acad. Sci. U.S.A. 89: 8087-8091, 1992.
34. TSAO, P. S., AOKI, N., LEFER, D. J., JOHNSON, G., III AND LEFER, A. M.: Time course of endothelial dysfunction and myocardial injury during myocardial ischemia reperfusion in the cat. Circulation 82: 1402-1412, 1990.
35. 2-adrenoreceptors. J. Cardiovasc. Pharmacol. 18: 487-495, 1991.
36. WEYRICH, A. S., MA, X.-L., LEFER, D. J., ALBERTINE, K. H. AND LEFEH, A. M.: In vivo neutralization of P-selectin protects the feline heart and endothelium in myocardial ischemia and reperfusion injury. J. Clin. Invest. 91: 2620-2629, 1993.
37. WILCOX, R. G., VON DER LIPPE, G., OLSSON, C. G., JENSEN, G., SKENE, A. M. AND HAMPTON, J. R.: Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian study of early thrombolysis (ASSET). Lancet 2: 525-530, 1988.
38. YAO, S. K., OBER, J. C., KRISHNASWAMI, A., FERGUSON, J. J., ANDERSON, H. V., GOLINO, P., BUJA, L. M. AND WILLERSON, J. T.: Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation 86: 1302-1309, 1992.
39. YUAN, Y. AND FLEMING, B. P.: A method for isolation and fluorescent labeling of rat neutrophil for intravital microvascular studies. Microvasc. Res. 40: 218-229, 1990.